Connect with us

Artificial Intelligence

Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update

GlobeNewswire

Published

on

NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today reported financial results for the quarter ended March 31, 2020 and provided a business update.
Financial and Business HighlightsContinued initial study to sequence ovarian tumors and validate ‘reach back’ process; study is on schedule to be completed in the second quarter of 2020Developing a potential COVID-19 vaccine in collaboration with Dr. Daniel Carter, former NASA Chief of the Biophysics and Advanced Materials Branch and recipient of NASA Inventor of the Year Awards and NASA Exceptional Service MedalSigned a letter of intent to acquire Quantitative Medicine, a biomedical analytics and computational biology company; closing is expected in the second quarter of 2020Signed a term sheet to acquire both BioDtech and Soluble Therapeutics and its HSC™ Technology; closing expected in second quarter of 2020.Streamlined capital structure with conversion of $2.1 million promissory note held by the company’s CEO to newly issued equityStrengthened balance sheet with issuance of 1.4 million shares of common stock and 1.4 million unregistered warrants for estimated gross proceeds of $2.2 million“We remain steadfast in our approach to assembling a portfolio of assets that leverages our unique collection of cancer tumors to develop and market AI-based, predictive models for personalized cancer treatments that improve patient outcomes,” commented Dr. Carl Schwartz, Predictive Oncology CEO. “Our collection of more than 150,000 cancer tumors, amassed and curated over a 10-year period, gives us a strong competitive advantage as we are the only company that can perform a ‘reach back’ to examine actual outcomes over an extended period of time. In collaboration with UPMC, we are on schedule to conclude an initial study of the application of artificial intelligence for treatment of ovarian cancer patients during the second quarter. We believe this critical research will provide us with a representative sample that successfully demonstrates the value of our tumor database, validates our processes and enables the next step in our path to commercialization.”“The pending acquisitions of several innovative biotechnology companies provides further encouragement, as we believe this consolidation will further enhance the breadth of our capabilities by leveraging high quality formulations and stable protein and peptide-based solutions for the rapid manufacture of vaccines and other drug therapies,” added Dr. Schwartz.Dr. Schwartz concluded, “We improved our liquidity position and streamlined our capital structure with the conversion of a $2.1 million convertible note, previously held by me, to newly issued equity. This action demonstrates my confidence in the commercial viability of our work, and when combined with the additional capital we raised through an equity offering, provides us with the cash runway to fund key clinical, regulatory and operational milestones for the next several quarters. In addition, we have significantly reduced the corporate structure of our Skyline Medical business to enable it to operate independently as we consider strategic alternatives for this business.”First Quarter 2020 Financial ResultsRevenues were $295,943 compared with $255,241 for the first quarter of 2019. Revenues in both years were primarily driven through the sale of Predictive Oncology’s proprietary STREAMWAY units, of which 5 units and 7 units were sold, respectively, in each of the first three months of 2020 and 2019. Gross margins remained strong at 69% in the first quarter of 2020 compared with 71% in the 2019 period. The slight decrease was due to Helomics’ costs surpassing the revenue earned. However, exclusive of Helomics, gross profit margin related to the Skyline Medical business in the first quarter of 2020 increased to 77%.Net loss was $4.5 million compared with $3.3 million for the first quarter of 2019. General & administrative expenses rose 89% to $2.8 million in the first quarter of 2020 as a result of additional costs related to the Helomics business. Operational expenses increased to $548,753, compared with $466,566 in the first quarter of 2019. Selling expenses decreased to $264,409 compared with $554,216 in the first quarter of 2019.OutlookManagement continues to focus its resources on the Helomics and TumorGenesis divisions and the Company’s primary mission of applying artificial intelligence to precision medicine, drug discovery and the mediums used to replace rats and mice in preliminary cancer studies. Management reaffirms that it is focusing the majority of its resources on maximizing opportunities within the Company’s precision medicine business.About Predictive Oncology Inc.Predictive Oncology (NASDAQ: POAI) operates through three segments (Domestic, International and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.Forward-Looking StatementsPortions of the narrative set for this document that are not statements of historical or current facts are forward-looking statements, in particular, the commercial outlook provided above. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors.These factors include, in addition to those mentioned elsewhere herein:We may not be able to continue operating without additional financing;Current negative operating cash flows;The terms of any further financing, which may be highly dilutive and may include onerous terms;Risks related to the 2019 merger with Helomics including; 1) significant goodwill could result in further impairment; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources;Risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns;Risks related to the transaction with Quantitative Medicine including: 1) completion of the transaction; 2) possible failure to realize anticipated benefits of the merger; 3) costs associated with the merger may be higher than expected; 4) the merger may result in the disruption of our existing businesses; and 5) distraction of management and diversion of resources;Risk that we will be unable to complete the transaction with InventaBioTech;Risk that we will be unable to protect our intellectual property or claims that we are infringing on others’ intellectual property;The impact of competition;Acquisition and maintenance of any necessary regulatory clearances applicable to applications of our technology;Inability to attract or retain qualified senior management personnel, including sales and marketing personnel;Risk that we never become profitable if our product is not accepted by potential customers;Possible impact of government regulation and scrutiny;Unexpected costs and operating deficits, and lower than expected sales and revenues, if any;Adverse results of any legal proceedings;The volatility of our operating results and financial condition, and,Other specific risks that may be alluded to in this report.Investor Relations Contact:Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com
— Tables Follow –
Predictive Oncology, Inc.
Consolidated Balance Sheets

Predictive Oncology, Inc.
Consolidated Statements of Operations
 

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Global Penetration Testing Market 2020-2025 – Increased Adoption of Cloud-based Penetration Testing Presents Opportunities

GlobeNewswire

Published

on

Dublin, July 10, 2020 (GLOBE NEWSWIRE) — The “Penetration Testing Market by Component (Solutions & Services), Application Area (Network Infrastructure, Web Application, Mobile Application, Cloud, & Social Engineering), Deployment Mode, Organization Size, Vertical, and Region – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.This market study covers the penetration testing market size across segments. It aims at estimating the market size and the growth potential of this market across segments categorized into components, application areas, verticals, and regions. The study also includes an in-depth competitive analysis of the key market players, along with their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.Significant rise in mobile-based business-critical applications require more secure endpoint protection is driving the overall growth of the penetration testing marketThe market growth is driven by various factors, such as the need to secure endpoint protection due to the significant rise in mobile-based business-critical applications and enterprises moving toward implementing security measures due to increased sophistication in cyberattacks.By application area, the mobile application penetration testing segment to grow at the highest CAGR during the forecast periodMobile application penetration testing is basically for mobile-based applications which is done by trying to break into various mobile applications through different vectors. The methodology is a security testing, which is used to analyze security from the inside of a mobile environment. The mobile application penetration testing methodology concentrates on file system, hardware, and network security.The test results can provide an organization with knowledge of the vulnerabilities in the mobile application, loopholes, and attack vectors before delivering an app to the user, thus offering insights on how to mitigate the potential risks of mobile applications and secure the user credentials associated with it. Mobile application users are becoming aware of the different threats and thus the deployment of mobile application penetration testing is rapidly increasing. Therefore, the mobile application penetration segment is expected to grow at the highest CAGR during the forecast period.By deployment mode, the cloud segment to grow at a higher rate during the forecast periodIn the cloud deployment mode, instead of implementing the software solution on the local hardware, businesses subscribe to the solution hosted on a third-party remotely located server. By opting for cloud-based solutions, organizations can avoid costs related to maintenance of infrastructure and technical staff.Cloud-based platforms are beneficial for organizations that have strict budgets for security investments. Small and Medium-sized Enterprises (SMEs) deploy their identity verification solutions on the cloud, as it saves them from investing their capital on security infrastructures. Hence, the cloud deployment segment is expected to grow at a higher CAGR.Asia-Pacific to register the highest growth rate during the forecast periodAsia-Pacific (APAC) has great scope for the growth of the penetration testing market. The penetration testing market in APAC is anticipated to grow significantly, due to increasing government investments in improving security posture, increased sophistication of cyberattacks, and the amalgamation of technologies, such as Artificial Intelligence (AI) and Machine Learning (ML) with penetration testing.The fast expansion of regional enterprises in APAC is another crucial variant contributing to the growth of the penetration testing market. In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews were conducted with key people.Key Topics Covered
1 IntroductionFor more information about this report visit https://www.researchandmarkets.com/r/fm043xResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Continue Reading

Artificial Intelligence

The Global Beauty Drinks Market is expected to grow from USD 1,943.82 Million in 2019 to USD 3,004.65 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.52%

GlobeNewswire

Published

on

New York, July 10, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Beauty Drinks Market Research Report by Ingredient, by Type, by Demography – Global Forecast to 2025 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p05913553/?utm_source=GNWClare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Continue Reading

Artificial Intelligence

Intrusion Detection and Prevention Market to grow at 9% CAGR to hit US $7 billion by 2025– Global Insights on Key Trends, Investments Analysis, Expansion Plans, Leading Players and Future Outlook: Adroit Market Research

GlobeNewswire

Published

on

Dallas,Texas, July 10, 2020 (GLOBE NEWSWIRE) — The “Intrusion Detection and Prevention Market by Component (Platform and Services), Type (Wireless-Based, Host-Based, Network-Based, and Network Behavior Analysis), Industry Vertical (BFSI, IT & Telecom, Healthcare, Retail, Manufacturing, and Others), and by Region, Global Forecast, 2018 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1542The global intrusion detection and prevention market size is anticipated to reach over USD 7 billion by 2025. It is expected that it will grow at a CAGR of over 9% during the forecast period 2018-2025. The intrusion detection and prevention is the procedure of examining the actions happening on the network and evaluating them for any future incidents or threats. Also, with the capability of automation and artificial intelligence, the intrusion detection, and prevention systems not only detect the prominent threats but they automatically take preventive measures against such threats. Hence, eliminates the need for checking every single security issue by the security administrator.The current and future intrusion detection and prevention market advances are defined to state the attractiveness of the market. Key impacting aspects focus on the intrusion detection and prevention market opportunities during the forecast period. Factors such as the rising number of cyber-attacks and data breaches are also the vital factor boosting the global intrusion detection and prevention market growth. Also, the growing data protection regulations and laws are other factors boosting the demand for intrusion detection and prevention solutions. However, However, the availability of free and open-source solutions are expected to impede market growth. Furthermore, the rising demand for cloud-based solutions and the growing BYOD trend in various organizations are some of the key factors expected to provide major growth opportunistic for the market in forthcoming years.Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/intrusion-detection-and-prevention-marketThe report also highlights various aspects of the global intrusion detection and prevention industry by analyzing the market through value chain analysis. Besides, the Intrusion Detection and Prevention market report covers different qualitative aspects of the intrusion detection and prevention industry in market drivers, key industry opportunities, and restraints. Furthermore, the report proposes a comprehensive valuation of the market competitiveness along with company profiling of residents as well as global vendors.The intrusion detection and prevention market has solid competition among the early established and new players. Also, to capture a competitive advantage over the other industry players many industry players are aiming potential markets by forming collaboration and partnerships, agreements, mergers & acquisitions, acquiring new startups & other companies, and escalating their business presence.Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1542In terms of industry vertical, the market is segmented into BFSI, IT & telecom, healthcare, retail, manufacturing, and others. The IT and telecom industry dominated the overall IDP market in 2019 and it is expected to do so throughout the forecast period. The growth of this segment is mainly attributed to the increasing attacks on IT infrastructure. However, the BFSI industry is anticipated to gather the major market growth during the forecast period due to the increasing adoption of smart banking solutions.The Asia-Pacific region is projected to experience the highest growth throughout the forecast period. On the contrary, the North American region dominated the overall market in 2019 and it is expected to maintain its position throughout the forecast period 2018-2025. The dominance of this region is mainly attributed to the stringent regulations and increasing government initiatives to counter cyber-attacks.Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1542The major players of the global intrusion detection and prevention market are Cisco, IBM, Palo Alto Networks, McAfee, Trend Micro Incorporated, Fortinet, FireEye, AT&T Intellectual Property, Darktrace, and Huawei Technologies Co. Moreover, the other potential players in the intrusion detection and prevention market are WatchGuard Technologies, Vectra AI, Armor Defense, Hilstone Networks, and AlertLogic. The recognized companies are coming up with innovative and new Intrusion Detection and Prevention Types. For instance, in April 2019, Trend Micro, a cybersecurity solutions provider partnered with Luxoft Holding, a digital strategy firm. With this partnership both the companies are planning to introduce Intrusion Prevention Systems (IPS) and Intrusion Detection System (IDS) to detect and prevent cyber-attacks on connected cars.Major points from Table of Contents:
Chapter 1    Introduction
Chapter 2    Research Methodology
Chapter 3    Executive Summary
Chapter 4    Market Outlook
Chapter 5    Intrusion Detection and Prevention Market by Component
Chapter 6    Intrusion Detection and Prevention Market by Type
Chapter 7    Intrusion Detection and Prevention Market by Industry Vertical
Chapter 8    Intrusion Detection and Prevention Market by Region
Chapter 9    Competitive Landscape
Chapter 10    Company Profiles
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html  About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager – Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn

Continue Reading

Trending

Roboticulized is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Roboticulized digests / hand picks the latest news about the AI industry and serves them to you daily.

Contact us: sales@picante.today

Editorial / PR Submissions

© Roboticulized.com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania